Castle Biosciences, Inc.

NASDAQ:CSTL

33.29 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -57.466-67.138-31.292-10.2845.277-6.367-12.37
Depreciation & Amortization 12.3310.5433.4070.4720.3580.3230.311
Deferred Income Tax -0.223-1.877-8.7361.397-2.280.272-0.163
Stock Based Compensation 51.21936.32121.748.3091.2490.2940.109
Change In Working Capital -6.63-0.007-4.1029.1480.044-7.359-0.641
Accounts Receivables -14.93-6.218-4.6311.663-0.896-8.408-0.428
Inventory -3.962-1.680.327-0.98-0.355-0.578-0.116
Accounts Payables 5.7070.582-0.1820.1690.5570.1970.371
Other Working Capital 6.5557.3090.3848.2960.7381.429-0.468
Other Non Cash Items 0.635-19.49733.040.8232.3670.5420.52
Operating Cash Flow -0.135-41.655-18.9839.8657.015-12.295-12.234
Investing Activities:
Investments In Property Plant And Equipment -13.621-5.632-3.483-4.751-0.937-0.277-0.495
Acquisitions Net 0.013-26.966-63.1840.003000
Purchases Of Investments -189.075-134.68900000
Sales Maturities Of Investments 186.5000000
Other Investing Activites -2.5620.7420.010.003000
Investing Cash Flow -16.183-166.545-66.657-4.748-0.937-0.277-0.495
Financing Activities:
Debt Repayment -0.142-0.122-0.008-27.359-0.015-5.418-2
Common Stock Issued 0.2690.8333.898330.04167.15410.420.293
Common Stock Repurchased -5.134-1.688-0.7810000
Dividends Paid 0000000
Other Financing Activities -2.4254.185.4293.20888.30315.83810.866
Financing Cash Flow -2.2981.5155.421305.8988.28815.8388.866
Other Information:
Effect Of Forex Changes On Cash -5.491000000
Net Change In Cash -24.107-206.685-80.219311.00794.3663.266-3.862
Cash At End Of Period 98.841122.948329.633409.85298.8454.4791.212